Diprivan and Norcuron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Norcuron (vecuronium bromide). Common drug interactions include oxygen saturation decreased among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Norcuron. It is created by eHealthMe based on reports of 91 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Norcuron?

Norcuron has active ingredients of vecuronium bromide. eHealthMe is studying from 430 Norcuron users. Check the latest studies of Norcuron.



On Jul, 05, 2026

91 people who take Diprivan and Norcuron together, and have interactions are studied.

Diprivan and Norcuron drug interactions.

What are the common drug interactions of Diprivan and Norcuron, by gender? *:

female:

  1. Oxygen saturation decreased
  2. Bradycardia (abnormally slow heart action)
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  4. Blood pressure decreased
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Abdominal distension
  7. Acute circulatory failure (shock)
  8. Ankle fracture
  9. Atrioventricular block complete (heart block complete)
  10. Blood catecholamines decreased

male:

  1. Renal failure (kidney dysfunction)
  2. Pain
  3. Injury
  4. Renal impairment (severely reduced kidney function)
  5. Stress
  6. Glomerular filtration rate decreased
  7. Hypertension (high blood pressure)
  8. Infection
  9. Laryngeal oedema (swelling of larynx)
  10. Renal injury (kidney injury)

What are the common drug interactions of Diprivan and Norcuron, by age (0-1 to 60+)? *:

0-1:

  1. Capillary leak syndrome (capillary leaks plasma)
  2. Hypotension (abnormally low blood pressure)

2-9:

  1. Hypertension (high blood pressure)
  2. Infection
  3. Arrhythmia (irregular heartbeat)
  4. Disease progression
  5. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  6. Pulmonary hypertension (increase in blood pressure in the lung artery)

10-19:

  1. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  2. Oxygen saturation decreased
  3. Prothrombin time ratio decreased
  4. Alanine aminotransferase increased
  5. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  6. Aspartate aminotransferase increased
  7. Blood pressure decreased
  8. Cardiac arrest
  9. Cardiac failure congestive
  10. Cardiomyopathy (weakening of the heart muscle)

20-29:

  1. Septic shock (shock due to blood infection)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Anxiety
  4. Depression
  5. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  6. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  7. Myoclonic jerks (involuntary twitching of a muscle or group of muscles)
  8. Pneumonia

30-39:

  1. Pulmonary oedema (fluid accumulation in the lungs)
  2. Anaesthetic complication pulmonary
  3. Convulsive threshold lowered
  4. Crystalluria present
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Drug maladministration
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Laceration (tearing of soft body tissue)
  9. Loss of consciousness
  10. Therapeutic procedural complication

40-49:

  1. Blood pressure decreased
  2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  3. Cardiac failure congestive
  4. Cardiomyopathy (weakening of the heart muscle)
  5. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  6. Erythema (redness of the skin)
  7. Hypotension (abnormally low blood pressure)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Acute circulatory failure (shock)
  10. Anaemia (lack of blood)

50-59:

  1. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  2. Anxiety
  3. Depression
  4. Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
  5. Septic shock (shock due to blood infection)
  6. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  7. Acute circulatory failure (shock)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Apnoea (suspension of external breathing)
  10. Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)

60+:

  1. Renal failure (kidney dysfunction)
  2. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  3. Laryngeal oedema (swelling of larynx)
  4. Renal impairment (severely reduced kidney function)
  5. Stress
  6. Acute respiratory distress syndrome
  7. Acute respiratory failure
  8. Anaesthetic complication
  9. Ankle fracture
  10. Atrioventricular block complete (heart block complete)

What are the existing conditions these people have? *

  1. Depression: 10 people, 10.99%
  2. Pneumonia: 9 people, 9.89%
  3. Psychotic Disorder: 8 people, 8.79%
  4. Pain: 8 people, 8.79%
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 8 people, 8.79%
  6. Agitation (state of anxiety or nervous excitement): 8 people, 8.79%
  7. Constipation: 5 people, 5.49%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Norcuron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprivan and Norcuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Norcuron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norcuron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on propofol and vecuronium bromide (the active ingredients of Diprivan and Norcuron, respectively), and Diprivan and Norcuron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: